Cargando…
Biomarkers and the Future of Treatment for Depression
Doctors have a variety of drug options for treatment of depression. But there is currently no way to determine which antidepressant will work best for a given patient, which means that many people continue to suffer while their doctors try a series of medications. As Marisa Toups and Madhukar H. Tri...
Autores principales: | Toups, Marisa, Trivedi, Madhukar H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Dana Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574808/ https://www.ncbi.nlm.nih.gov/pubmed/23447792 |
Ejemplares similares
-
Kynurenine pathway metabolites selectively associate with impaired associative memory function in depression
por: Chirico, Margherita, et al.
Publicado: (2020) -
Pro-Inflammatory Cytokines as Predictors of Antidepressant Effects of Exercise in Major Depressive Disorder
por: Rethorst, Chad D., et al.
Publicado: (2012) -
Addressing adherence to antidepressant treatment for depression
por: Mayes, Taryn L., et al.
Publicado: (2020) -
Treatment strategies to improve and sustain remission in major depressive disorder
por: Madhukar H., Trivedi, et al.
Publicado: (2008) -
Circulating microRNA associated with future relapse status in major depressive disorder
por: Li, Qingqin S., et al.
Publicado: (2022)